ELI LILLY & Co is 150.0x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.070 T vs $7.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TGTX | LLY |
|---|---|---|
| Market cap | $7.14 B | $1.070 T |
| US-listed rank | #1140 | #10 |
| Revenue (latest FY) | $616.29M | $65.18B |
| Net income (latest FY) | $447.20M | $20.64B |
| Net margin | 72.6% | 31.7% |
| P/E (trailing FY) | 16.0 | 51.8 |
| SEC filings | 1,133 | 989 |
ELI LILLY & Co is 150.0x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.070 T vs $7.14 B).
In their latest fiscal years, TG THERAPEUTICS, INC. reported $616.29M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: TG THERAPEUTICS, INC. and ELI LILLY & Co, or browse the full rankings.